Inavolisib with palbociclib and fulvestrant for treating recurrent oestrogen receptor-positive HER2-negative PIK3CA-mutated advanced breast cancer after adjuvant endocrine treatment TA1208 18 November ...
NICE is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of NICE shares has decreased $1.76 since the market last closed. This is a 1.92 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
See NICE Ltd. (NICE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results